Tuesday, November 24, 2015

EyewireTV - Pfizer — Allergan Merger; Breaking News from AAO (Part 2)

In this week’s EyewireTV, Pfizer and Allergan enter into a definitive agreement to combine in a deal worth about $160 billion – the biggest deal ever in the pharmaceutical industry; and Carl Zeiss Meditec introduces the IOL Master 700 with swept-source biometry to the US market. Also, Leica Microsystems launches the Proveo 8 ophthalmic microscope platform for cataract and vitreoretinal surgeries. (1084 Views)

Watch Video

Wednesday, November 18, 2015

EyewireTV — Breaking News from the AAO Meeting in Las Vegas (Part 1 of 2)

In this week’s EyewireTV, Abbott Medical Optics launches the Whitestar Signature PRO Phacoemulsification System in the United States; and Alcon introduces Contoura Vision, a topography-guided LASIK treatment designed to provide surgeons the ability to perform more personalized laser procedures. Also, Clarity Medical Systems announces the commercial availability of its Holos IntraOp intraoperative wavefront aberrometer. (2648 Views)

Watch Video

Wednesday, November 11, 2015

EyewireTV — Allergan Dry Eye Pipeline; Raindrop Inlay PMA Submission

In this week's EyewireTV, Allergan has expanded its dry eye pipeline by entering into an exclusive licensing agreement with Mimetogen Pharmaceuticals, the maker of phase 3 dry eye drug candidate, tavilermide (MIM-D3); and the FDA accepts ReVision Optics’ premarket approval submission for the Raindrop Near Vision Inlay. Also, a newly published international study shows that two implanted iStent Trabecular Micro-Bypass Stents provide sustained reduction in IOP through 3 years. (1846 Views)

Watch Video

Wednesday, November 04, 2015

EyewireTV — Allergan Merger Talks; Raindrop Inlay Data

In this week’s EyewireTV, Allergan and Pfizer confirm that the companies are in preliminary discussions regarding a potential blockbuster merger, and new clinical data supporting the efficacy of the Raindrop Corneal Inlay are published as ReVision Optics remains on track for a 2016 launch of the inlay. Also, Avedro receives approval for its KXL cross-linking system from the China Food and Drug Administration. (2446 Views)

Watch Video

Wednesday, October 28, 2015

EyewireTV — Valeant Eye Care Subpoena; Ziemer Z8 Approval; New Lifitegrast Data

In this week’s EyewireTV, Valeant discloses in a securities filing it received a subpoena from the Justice Department concerning a criminal investigation “regarding payments and agreements between” its Bausch + Lomb business and medical professionals; and Ziemer receives FDA 510(k) clearance for the FEMTO LDV Z8, which is capable of performing refractive, cornea, and cataract procedures. Also, in an exclusive interview with EyewireTV, Shire CEO Flemming Ornskov, MD, provides his reaction to the new OPUS-3 data, which puts lifitegrast, a dry eye treatment candidate, back on track for a 2016 launch. (2496 Views)

Watch Video

Wednesday, October 21, 2015| , Shire,

EyewireTV — Lifitegrast Approval Delayed; Cross-linking Application

In this week's EyewireTV, the FDA does not approve Shire’s blockbuster dry eye drug candidate lifitegrast, requesting more information; and Avedro plans to resubmit a new drug application to the FDA for its corneal cross-linking products, which include riboflavin ophthalmic solution and the KXL System. Also, Valeant Pharmaceuticals receives subpoenas from federal prosecutors seeking information related to how it prices drugs, distributes them, and helps patients afford the medicines. (1856 Views)

Watch Video

Wednesday, October 14, 2015

EyewireTV — Meaningful Use Changes; Premium IOL Copayments

In this week’s EyewireTV, new meaningful use rules detailing changes to stages 1 and 2 of the electronic health record incentive program, stage 3 requirements, and 2015 EHR certification criteria are released; and a neuro-vision concussion test is unveiled that aims to better understand the severity of patients' head trauma and assess their recovery over time. Also, leading international ophthalmologists discuss whether they believe the European Union should standardize copayment procedures for cataract surgery with premium lenses. (1840 Views)

Watch Video

Wednesday, October 07, 2015

EyewireTV — ICD-10 Coding; Phase 3 Gene Therapy Trial for Retinal Dystrophies

In this week’s EyewireTV, resources pertaining to the ICD-10 coding system, which became effective on October 1, are provided; and Spark Therapeutics announces positive top-line results from a phase 3 pivotal trial of its experimental gene therapy for the treatment of inherited retinal dystrophies. Also, the first patient receives a human embryonic stem cell operation in the UK that doctors hope will be an effective treatment for wet AMD. (2337 Views)

Watch Video

Wednesday, September 30, 2015

EyewireTV — Raindrop Near Vision Inlay PMA; MillennialEYE Live

In this week's EyewireTV, ReVision Optics submits to the FDA the fourth and final module of the company’s premarket approval application for the Raindrop near vision inlay; and Ocular Therapeutix submits a new drug application to the FDA for Dextenza (dexamethasone 0.4 mg) for the treatment of ocular pain following ophthalmic surgery. Also, future and current leaders in ophthalmology discuss the hottest topics from annual MillennialEYE Live meeting in Hollywood. (3051 Views)

Watch Video

Wednesday, September 23, 2015

EyewireTV — Rhopressa Back on Track; Sun Pharma Buys InSite

In this week's EyewireTV, glaucoma drug candidate Rhopressa achieves its primary efficacy endpoint in its second phase 3 trial, Rocket 2, and a subsidiary of Sun Pharmaceutical Industries, India’s largest pharmaceutical company, enters into an agreement to acquire InSite Vision for about $48 million. Also, the FDA accepts for review Bausch + Lomb’s new drug application for glaucoma drug candidate Vesneo (latanoprostene bunod 0.024%). (2290 Views)

Watch Video

Wednesday, September 16, 2015

EyewireTV — Coveted Product Approvals from Abroad

In this week’s EyewireTV, leading ophthalmologists from the United States and Europe discuss technologies and procedures currently available in Europe that they would like to see approved in the United States. (2686 Views)

Watch Video

Tuesday, September 08, 2015

EyewireTV — Breaking Industry News from the ESCRS Meeting in Barcelona

In this week's EyewireTV, Allergan President and CEO Brent Saunders talks about Allergan’s acquisition of AqueSys; and Heidelberg Engineering unveils a new cataract and refractive imaging platform. Also, Carl Zeiss Meditec receives FDA 510(k) clearance for its AngioPlex OCT Angiography, the first such technology to receive clearance in the United States. (5230 Views)

Watch Video
Load More